glycerol has been researched along with Hematologic Diseases in 7 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "paclitaxel clearance was 10." | 2.70 | Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. ( Buijs, D; Gelderblom, H; Nooter, K; Ouwens, L; Sparreboom, A; Stoter, G; van Zomeren, DM; Verweij, J, 2002) |
| " Pharmacokinetic parameters of unbound and total cisplatin and of topotecan lactone and total drug were not significantly different from historic control values (P>or=0." | 1.31 | Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies. ( Brouwer, E; de Jonge, MJ; Gelderblom, H; Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; van der Burg, ME; Verweij, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, ST | 1 |
| Wang, YP | 1 |
| Chen, YH | 1 |
| Lin, CT | 1 |
| Li, WS | 1 |
| Wu, HC | 1 |
| Monguzzi, G | 1 |
| Clavenna, G | 1 |
| Di Liberto, C | 1 |
| Amigoni, S | 1 |
| Torchio, P | 1 |
| Gelderblom, H | 2 |
| Loos, WJ | 1 |
| Verweij, J | 2 |
| van der Burg, ME | 1 |
| de Jonge, MJ | 1 |
| Brouwer, E | 1 |
| Nooter, K | 2 |
| Stoter, G | 2 |
| Sparreboom, A | 2 |
| van Zomeren, DM | 1 |
| Buijs, D | 1 |
| Ouwens, L | 1 |
| Herve, P | 1 |
| Masse, M | 1 |
| Potron, G | 1 |
| Kieffer, Y | 1 |
| Carbillet, JP | 1 |
| Bidet, A | 1 |
| Bosset, JF | 1 |
| Peters, A | 1 |
| Gimferrer, E | 1 |
| Baiget, M | 1 |
| Rutllant, ML | 1 |
| Gottfried, EL | 1 |
| Robertson, NA | 1 |
1 trial available for glycerol and Hematologic Diseases
| Article | Year |
|---|---|
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.
Topics: Aged; Antineoplastic Agents, Phytogenic; Ascitic Fluid; Biological Availability; Female; Gastrointes | 2002 |
6 other studies available for glycerol and Hematologic Diseases
| Article | Year |
|---|---|
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Cell Line, Tumor; Cell Survival | 2018 |
[Importance of sodium ascorbate and glucose in antagonizing the most frequent side effects of glycerol on the blood and kidneys].
Topics: Animals; Ascorbic Acid; Glucose; Glycerol; Hematologic Diseases; Kidney Diseases; Rabbits | 1981 |
Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies.
Topics: Animals; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Fema | 2002 |
[Method of cryopreservation of platelets at - 196 degrees C. Clinical application].
Topics: Adult; Aged; Blood Platelets; Blood Preservation; Blood Transfusion; Cell Survival; Cryoprotective A | 1977 |
[Experiences with the glycerol erythrocyte lysis test (author's transl)].
Topics: Cell Fractionation; Erythrocytes; Female; Fetal Blood; Fetal Diseases; Glycerol; Hematologic Disease | 1978 |
Glycerol lysis time as a screening test for erythrocyte disorders.
Topics: Anemia, Hypochromic; Cell Membrane; Erythrocytes; Erythrocytes, Abnormal; Glycerol; Hematologic Dise | 1974 |